Moderna's investigational RSV vaccine is reported to have lower efficacy compared to GSK's approved shot Arexvy. The FDA issues new guidance on production reporting and alternate facilities in the pharmaceutical industry.
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about a tossed PhRMA lawsuit, Secrecy clauses & much more news.. https://t.co/soSzCVuBqx #pharma #Medicare #China #FDA #AIDS #UNICEF $GILD $TAK $EXAI $WUXAY $CBAY
In today's Pharmalittle roundup, we're reading about Moderna's RSV vaccine, Aurobindo problems, and more. https://t.co/vEtxVWsbHc
ICYMI: The efficacy of Moderna’s investigational RSV vaccine appears to wane faster than GSK’s approved shot Arexvy $MRNA https://t.co/Rx4UEVWiEt
Also this ... #Pinksheet #pharma: The Quality Lowdown: The Latest FDA Guidance On Production Reporting, Alternate Facilities, Sources https://t.co/cx41ECTMQq
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about Moderna’s RSV vaccine, Aurobindo problems & Much more news.. https://t.co/W5j9CgFGqq #pharma #vaccines #obesity #weightloss #patents #RSV $MRNA $PFE $NVO $GSK